TGV Sraac Ltd
Incorporated in 1981, TGV Sraac Ltd is a producer of Chlor-Alkali products, Chloromethane and also manufactures Castor Derivatives and Fatty Acids[1]
- Market Cap ₹ 1,222 Cr.
- Current Price ₹ 114
- High / Low ₹ 142 / 87.7
- Stock P/E 10.4
- Book Value ₹ 110
- Dividend Yield 0.87 %
- ROCE 10.4 %
- ROE 8.01 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 1.06 times its book value
Cons
- The company has delivered a poor sales growth of 11.0% over past five years.
- Dividend payout has been low at 10.8% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 769 | 777 | 816 | 908 | 1,046 | 1,205 | 1,040 | 1,009 | 1,525 | 2,326 | 1,546 | 1,749 | 1,861 | |
| 670 | 669 | 710 | 776 | 866 | 974 | 884 | 860 | 1,219 | 1,786 | 1,412 | 1,520 | 1,584 | |
| Operating Profit | 99 | 108 | 107 | 132 | 180 | 231 | 157 | 149 | 306 | 539 | 134 | 230 | 277 |
| OPM % | 13% | 14% | 13% | 15% | 17% | 19% | 15% | 15% | 20% | 23% | 9% | 13% | 15% |
| -19 | 0 | 5 | 9 | 7 | -6 | 8 | 10 | 7 | 6 | 58 | 14 | 16 | |
| Interest | 40 | 40 | 44 | 60 | 58 | 71 | 44 | 48 | 35 | 30 | 25 | 30 | 27 |
| Depreciation | 36 | 36 | 35 | 47 | 77 | 58 | 56 | 63 | 69 | 74 | 84 | 88 | 107 |
| Profit before tax | 4 | 32 | 33 | 34 | 53 | 95 | 64 | 48 | 209 | 442 | 83 | 125 | 159 |
| Tax % | -11% | 30% | 26% | 52% | 44% | 28% | 26% | 40% | 36% | 18% | 27% | 26% | |
| 5 | 22 | 24 | 17 | 30 | 68 | 47 | 29 | 134 | 362 | 61 | 92 | 117 | |
| EPS in Rs | 0.64 | 2.81 | 2.95 | 1.90 | 3.22 | 7.08 | 4.65 | 2.70 | 12.53 | 33.77 | 5.67 | 8.60 | 10.94 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 3% | 18% | 12% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 11% |
| 3 Years: | 5% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 14% |
| 3 Years: | -12% |
| TTM: | 399% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 39% |
| 3 Years: | -5% |
| 1 Year: | 0% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 15% |
| 3 Years: | 16% |
| Last Year: | 8% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 75 | 79 | 83 | 87 | 92 | 97 | 102 | 107 | 107 | 107 | 107 | 107 |
| Reserves | 181 | 199 | 236 | 259 | 290 | 382 | 435 | 503 | 636 | 939 | 989 | 1,071 |
| 332 | 346 | 451 | 476 | 439 | 328 | 420 | 499 | 461 | 234 | 321 | 357 | |
| 208 | 194 | 202 | 255 | 269 | 289 | 319 | 344 | 393 | 402 | 374 | 432 | |
| Total Liabilities | 796 | 818 | 972 | 1,078 | 1,091 | 1,095 | 1,275 | 1,453 | 1,598 | 1,683 | 1,792 | 1,968 |
| 431 | 444 | 660 | 698 | 669 | 636 | 808 | 774 | 902 | 1,042 | 1,048 | 1,269 | |
| CWIP | 126 | 124 | 0 | 0 | 13 | 77 | 29 | 125 | 55 | 11 | 168 | 12 |
| Investments | 2 | 2 | 2 | 9 | 14 | 10 | 8 | 89 | 89 | 31 | 33 | 35 |
| 237 | 248 | 309 | 371 | 394 | 373 | 430 | 465 | 551 | 600 | 542 | 651 | |
| Total Assets | 796 | 818 | 972 | 1,078 | 1,091 | 1,095 | 1,275 | 1,453 | 1,598 | 1,683 | 1,792 | 1,968 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78 | 65 | 50 | 142 | 153 | 202 | 122 | 132 | 168 | 429 | 164 | 195 | |
| -75 | -52 | -132 | -109 | -75 | -55 | -188 | -163 | -147 | -169 | -223 | -170 | |
| -12 | -2 | 91 | -33 | -76 | -145 | 65 | 58 | -38 | -255 | 49 | -3 | |
| Net Cash Flow | -9 | 11 | 9 | -0 | 2 | 2 | -0 | 26 | -18 | 5 | -9 | 22 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 25 | 25 | 29 | 30 | 37 | 30 | 29 | 36 | 56 | 36 | 44 | 52 |
| Inventory Days | 77 | 50 | 82 | 79 | 89 | 125 | 167 | 126 | 101 | 90 | 101 | 108 |
| Days Payable | 93 | 65 | 77 | 98 | 80 | 67 | 73 | 81 | 66 | 42 | 38 | 75 |
| Cash Conversion Cycle | 8 | 10 | 34 | 11 | 45 | 89 | 123 | 81 | 90 | 84 | 107 | 86 |
| Working Capital Days | -81 | -83 | -80 | -97 | -72 | -11 | -22 | -34 | -1 | 17 | 1 | -5 |
| ROCE % | 11% | 13% | 11% | 12% | 13% | 22% | 12% | 9% | 21% | 38% | 5% | 10% |
Documents
Announcements
-
Reg. 30 - Report On Relodgement Of Transfer Requests
1d - Monthly SEBI special window report as of 31 Oct 2025: zero re-lodged transfer requests.
-
Reg. 30 - Report On Re-Lodgement Of Transfer Requests
31 Oct - Report: zero re-lodgement requests for transfer-to-demat under SEBI special window as of September 2025.
-
Board Meeting Intimation for Approving Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended September, 30 2025.
30 Oct - Board meeting on 12 November 2025 to consider unaudited Q2/H1 results for period ended 30 Sep 2025; trading window closed.
-
Intimation Regarding Failure Of Transformer - Estimated Loss Of Production.
26 Oct - Transformer winding failure causing about 120 TPD caustic and 106 TPD chlorine loss for about 60 days.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
17 Oct - Newspaper advertisement - Intimation to CRPS (Cumulative Redeemable Preference Shares) Resident Indians (RIs) (3rd Instalment) Redemption regarding transfer of unpaid/un-claimed Redemption amount for the FY …
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
TGVSL (formerly Sree Rayalaseema Alkalies and Allied Chemicals Ltd.) is the flagship company of the TGV Group. It is an ISO 9001, ISO 14001 and OSHAS 18001 certified manufacturer of Chlor-Alkali products and also manufactures Castor Derivatives and Fatty Acids. It also runs a commercial Power Project of 28MW. TGV does B2B marketing directly to its industrial customers and through traders for other customers